PharmiWeb.com - Global Pharma News & Resources
26-Oct-2018

Global Osteoarthritis Market and Competitive Landscape Report 2018: Clinical Trials by Stages, Pharmacological Class & Company

Global Osteoarthritis Market and Competitive Landscape Report 2018: Clinical Trials by Stages, Pharmacological Class & Company

PR Newswire

DUBLIN, Oct. 26, 2018

DUBLIN, Oct. 26, 2018 /PRNewswire/ --

The "Global Osteoarthritis Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

The latest research Global Osteoarthritis Market and Competitive Landscape - 2018, provides comprehensive insights into Osteoarthritis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Osteoarthritis market size and drug sales. This research also provides insights into Osteoarthritis epidemiology and late stage pipeline.

The research is classified into following sections - Osteoarthritis overview with definitions, symptoms, etiology, diagnosis, treatment options; Osteoarthritis pipeline insights covering late stage clinical trials pipeline; Osteoarthritis prevalence trends by countries; Osteoarthritis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan.

Research Scope:

  • Osteoarthritis pipeline: Find out the drugs in clinical trials for Osteoarthritis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Osteoarthritis epidemiology: Find out the prevalence of Osteoarthritis by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
  • Osteoarthritis products: Identify key products marketed and prescribed for Osteoarthritis by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Osteoarthritis market size: Find out the market size for Osteoarthritis drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
  • Osteoarthritis drug sales: Find out the sales of Osteoarthritis drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Osteoarthritis drugs sales forecast: Sales forecast for Osteoarthritis drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Osteoarthritis market share analysis: Find out the market shares of Osteoarthritis drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research:

  • Evaluate commercial market opportunities for Osteoarthritis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Osteoarthritis market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Osteoarthritis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

For more information about this report visit https://www.researchandmarkets.com/research/lbfb3k/global?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-osteoarthritis-market-and-competitive-landscape-report-2018-clinical-trials-by-stages-pharmacological-class--company-300738718.html

SOURCE Research and Markets

Editor Details

Last Updated: 26-Oct-2018